DE60217493D1 - Verwendung von carbamat-verbindungen zur prävention oder behandlung von neuropathischen schmerzen und migräneartigen kopfschmerzen - Google Patents

Verwendung von carbamat-verbindungen zur prävention oder behandlung von neuropathischen schmerzen und migräneartigen kopfschmerzen

Info

Publication number
DE60217493D1
DE60217493D1 DE60217493T DE60217493T DE60217493D1 DE 60217493 D1 DE60217493 D1 DE 60217493D1 DE 60217493 T DE60217493 T DE 60217493T DE 60217493 T DE60217493 T DE 60217493T DE 60217493 D1 DE60217493 D1 DE 60217493D1
Authority
DE
Germany
Prior art keywords
migrant
headache
prevention
treatment
neuropathic pain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60217493T
Other languages
English (en)
Other versions
DE60217493T2 (de
Inventor
C Codd
R Plata-Salaman
Boyu Zhao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Application granted granted Critical
Publication of DE60217493D1 publication Critical patent/DE60217493D1/de
Publication of DE60217493T2 publication Critical patent/DE60217493T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
DE60217493T 2001-07-16 2002-07-11 Verwendung von carbamat-verbindungen zur prävention oder behandlung von neuropathischen schmerzen und migräneartigen kopfschmerzen Expired - Lifetime DE60217493T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US30568701P 2001-07-16 2001-07-16
US305687P 2001-07-16
PCT/US2002/021787 WO2003007936A1 (en) 2001-07-16 2002-07-11 Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
US192973 2002-07-11
US10/192,973 US20030069306A1 (en) 2001-07-16 2002-07-11 Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain

Publications (2)

Publication Number Publication Date
DE60217493D1 true DE60217493D1 (de) 2007-02-22
DE60217493T2 DE60217493T2 (de) 2007-11-15

Family

ID=26888550

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60217493T Expired - Lifetime DE60217493T2 (de) 2001-07-16 2002-07-11 Verwendung von carbamat-verbindungen zur prävention oder behandlung von neuropathischen schmerzen und migräneartigen kopfschmerzen

Country Status (23)

Country Link
US (3) US20030069306A1 (de)
EP (1) EP1406606B1 (de)
JP (1) JP4362368B2 (de)
KR (1) KR100995936B1 (de)
CN (2) CN1592617A (de)
AU (1) AU2002354909B2 (de)
BR (1) BR0211240A (de)
CA (1) CA2454047C (de)
CY (1) CY1106038T1 (de)
DE (1) DE60217493T2 (de)
DK (1) DK1406606T3 (de)
ES (1) ES2278035T3 (de)
HK (1) HK1063288A1 (de)
HU (1) HUP0401110A3 (de)
IL (1) IL159846A0 (de)
MX (1) MXPA04000555A (de)
NO (1) NO20040177L (de)
NZ (1) NZ549751A (de)
PL (1) PL368112A1 (de)
PT (1) PT1406606E (de)
RS (1) RS50946B (de)
RU (1) RU2299729C2 (de)
WO (1) WO2003007936A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0523550D0 (en) 2005-11-18 2005-12-28 Hunter Fleming Ltd Therapeutic uses of steroidal compounds
KR102489052B1 (ko) * 2016-05-19 2023-01-16 에스케이바이오팜 주식회사 섬유근육통 또는 섬유근육통의 연관된 기능적 증후군을 예방 또는 치료하기 위한 카바메이트 화합물의 용도

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313692A (en) * 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3278380A (en) * 1962-02-06 1966-10-11 Armour Pharma Methods of calming employing diphenyl hydroxy carbamate compounds
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
CA2416819C (en) * 2000-07-21 2011-03-22 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain

Also Published As

Publication number Publication date
US20030069306A1 (en) 2003-04-10
DE60217493T2 (de) 2007-11-15
HUP0401110A3 (en) 2012-09-28
BR0211240A (pt) 2004-07-27
RU2299729C2 (ru) 2007-05-27
CA2454047C (en) 2011-06-21
MXPA04000555A (es) 2005-06-20
PT1406606E (pt) 2007-03-30
RU2004100965A (ru) 2005-02-20
AU2002354909B2 (en) 2006-10-05
KR100995936B1 (ko) 2010-11-22
US20060293383A1 (en) 2006-12-28
HUP0401110A2 (hu) 2004-09-28
CY1106038T1 (el) 2011-04-06
EP1406606B1 (de) 2007-01-10
NO20040177L (no) 2004-03-16
CN1592617A (zh) 2005-03-09
HK1063288A1 (en) 2004-12-24
RS4504A (en) 2006-12-15
PL368112A1 (en) 2005-03-21
JP4362368B2 (ja) 2009-11-11
IL159846A0 (en) 2004-06-20
ES2278035T3 (es) 2007-08-01
CA2454047A1 (en) 2003-01-30
NZ549751A (en) 2008-04-30
US20050009905A1 (en) 2005-01-13
KR20040016993A (ko) 2004-02-25
JP2004536856A (ja) 2004-12-09
CN101669933A (zh) 2010-03-17
WO2003007936A8 (en) 2004-10-14
WO2003007936A1 (en) 2003-01-30
RS50946B (sr) 2010-08-31
DK1406606T3 (da) 2007-03-05
EP1406606A1 (de) 2004-04-14

Similar Documents

Publication Publication Date Title
DE50009504D1 (de) Verwendung von retigabin zur behandlung von neuropathischen schmerzen
DE60114580D1 (de) Verwendung von cyanochinolinen zur behandlung oder inhibierung von dickdarmpolypen
ATE251903T1 (de) Verwendung von phosphororganischen verbindungen zur therapeutischen und prophylaktischen behandlung von infektionen
DE60142590D1 (de) Verwendung von Botulinum Toxin zur Behandlung von post-operative Schmerzen
DE50212701D1 (de) Bestrahlungsanordnung zur behandlung von akne und aknenarben
DE60223694D1 (de) Pflaster zur behandlung von funktionsstörungen und störungen des nagelwachstums
DE60230869D1 (de) 4-(phenylpiperazinylmethyl) benzamidderivate und deren verwendung zur behandlung von schmerzen, angst oder gastrointestinalen störungen
ATE376444T1 (de) Ibandronsäure zur behandlung und vorbeugung von osteoporose
DE60208186D1 (de) Chinazolin- und chinazolinähnliche verbindungen zur behandlung von integrinvermittelten erkrankungen
DE602004003587D1 (de) Kosmetische verwendung einer zusammensetzung mit mindestens einem oxazolin als wirkstoff, als abnehmprodukt und/oder zur prävention und/oder behandlung von cellulite
ATE369130T1 (de) Carbamatverbindungen zur vorbeugung und behandlung von bewegungsstörungen
DE69925865D1 (de) 4-(aminomethyl)-piperidinbenzamide zur behandlung von gastrointestinalen störungen
DE60220043D1 (de) Carbamatverbindungen zur vorbeugung oder behandlung von neurodegenerativen störungen
DE60216495D1 (de) Vaginale zusammensetzung enthaltend lidocaine zur behandlung von gebärmutterrhythmusstörung
DE60208221D1 (de) Heterozyklische verbindungen zur behandlung von harnwegserkrankungen
DE60136477D1 (de) Retinoide zur behandlung von emphysem
DE60238765D1 (de) Carbamatverbindungen zur behandlung von schmerz
DE69943089D1 (de) Methode zur behandlung von staphylokokkeninfektionen
DE60224004D1 (de) Verwendung von il-18 hemmern zur behandlung und/oder prävention von herzkrankheiten
DE60027429D1 (de) Dihydrobenzodiazepinen und deren verwendung zur behandlung von dyslipidämien
DE60214355D1 (de) Exemestan zur behandlung von hormonabhängigen störungen
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis
ATE362923T1 (de) 4-(phenylpiperazinylmethyl)benzamidderivate und deren verwendung zur behandlung von schmerzen oder gastrointestinalen erkrankungen
ATE346597T1 (de) Carbamate verbindungen zur behandlung oder verhutung von psychotischen krankheiten
DE60223707D1 (de) Calcium-l-threonat zur behandlung von knochenfrakturen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition